MOLECULAR PHARMACOLGY USA by Molecular Pharmacology (USA), Ltd. (MLPH)

About MOLECULAR PHARMACOLGY USA by Molecular Pharmacology (USA), Ltd. (MLPH)

Molecular Pharmacology (USA) Ltd. engages in the development of pharmaceutical products. It discovers and develops analgesic and anti-inflammatory products based on the proprietary MPL-TL compound. The MPL-TL compound is an oligopeptide which is a new key active ingredient that targets a different part of the pain and inflammation cascade than other analgesic and anti-inflammatory drugs. The company was founded on May 1, 2002 and is headquartered in Stroudsburg, PA.

MOLECULAR PHARMACOLGY USA by Molecular Pharmacology (USA), Ltd. News